Bio Essence Corporation
BIOE
$0.40
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 7,816.15% | -78.30% | 129.11% | -645.65% | 97.70% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | -66.67% | 200.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -24.47% | -18.97% | -15.94% | -11.54% | -98.73% |
| Change in Net Operating Assets | 24.50% | 70.82% | -41.95% | -61.84% | 33.47% |
| Cash from Operations | 563.69% | 11.44% | 742.91% | -106.17% | 18.48% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -42.10% | 170.02% | -76.76% | 211.43% | -347.81% |
| Total Debt Repaid | -271.84% | -51.27% | 22.78% | -127.87% | 69.49% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -702.65% | 5.72% | -779.35% | 105.47% | -34.06% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -200.00% | -- | 100.00% | 95.10% | -240.89% |